Latest Period
Q1 2026
Security Snapshot
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) Institutional Ownership
CUSIP: 64130M209
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
31
Shares (Excl. Options)
11,774,850
Price
$0.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- NMTC on Nasdaq
- Shares outstanding
- 8,477,622
- Price per share
- $0.78
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 11,774,850
- Total reported value
- $9,144,296
- % of total 13F portfolios
- 0%
- Share change
- -804,556
- Value change
- -$618,566
- Number of holders
- 31
- Price from insider filings
- $0.78
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock is tracked under CUSIP 64130M209.
- 31 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 37 to 31 between Q4 2025 and Q1 2026.
- Reported value moved from $9,437,810 to $9,144,296.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 31 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 64130M209:
Significant Owners of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MERCHANT ADVENTURE FUND, L.P. | 14% | $2,478,000 | 4,200,000 | MERCHANT ADVENTURE FUND, L.P. | 31 Dec 2024 | |||
| Bleichroeder LP | 8% | $2,800,000 | 4,000,000 | Bleichroeder LP | 30 Jun 2025 | |||
| Sio Capital Management, LLC | 4.7% | -34% | $2,098,132 | -$1,033,699 | 2,360,635 | -33% | Sio Capital Management, LLC | 30 Sep 2025 |
| AWM Investment Company, Inc. | 4.8% | $1,388,959 | 2,354,167 | AWM Investment Company, Inc. | 31 Mar 2025 | |||
| MANCHESTER MANAGEMENT CO LLC | 4.9% | $934,166 | 1,583,332 | JAMES E. BESSER | 31 Dec 2024 | |||
| LYTTON LAURENCE W | 2.6% | $764,220 | 1,295,288 | LYTTON LAURENCE W | 31 Mar 2025 | |||
| Nantahala Capital Management, LLC | 2.6% | $471,270 | 798,762 | Nantahala Capital Management, LLC | 30 Sep 2024 | |||
| Pratt Brian | 7.4% | $487,133 | 627,344 | Brian Pratt | 14 Apr 2026 |
As of 31 Mar 2026, 31 institutional investors reported holding 11,774,850 shares of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC). This represents 139% of the company’s total 8,477,622 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) together control 139% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bleichroeder LP | 47% | 4,000,000 | 0% | 0.54% | $3,106,000 |
| BARD ASSOCIATES INC | 22% | 1,840,498 | -0.35% | 0.36% | $1,429,147 |
| PERKINS CAPITAL MANAGEMENT INC | 17% | 1,473,000 | 0% | 1.1% | $1,143,784 |
| VANGUARD CAPITAL MANAGEMENT LLC | 16% | 1,397,329 | 0% | 0% | $1,085,725 |
| RENAISSANCE TECHNOLOGIES LLC | 7.7% | 655,446 | -14% | 0% | $508,954 |
| GEODE CAPITAL MANAGEMENT, LLC | 7.3% | 615,606 | +22% | 0% | $478,075 |
| Sio Capital Management, LLC | 5.9% | 496,614 | -56% | 0.06% | $385,621 |
| VANGUARD FIDUCIARY TRUST CO | 3.4% | 292,081 | 0% | 0% | $226,947 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 3.1% | 261,953 | +39% | 0.03% | $203,407 |
| Cambridge Investment Research Advisors, Inc. | 2% | 171,000 | 0% | 0% | $133,000 |
| NORTHERN TRUST CORP | 1.3% | 112,123 | 0% | 0% | $87,064 |
| Belpointe Asset Management LLC | 0.88% | 75,000 | 0% | $58,238 | |
| Legato Capital Management LLC | 0.73% | 61,642 | +39% | 0% | $47,865 |
| STATE STREET CORP | 0.7% | 59,499 | 0% | 0% | $46,201 |
| XTX Topco Ltd | 0.51% | 43,283 | -49% | 0% | $33,609 |
| J.W. COLE ADVISORS, INC. | 0.42% | 36,000 | 0% | 0% | $27,954 |
| Focus Financial Network, Inc. | 0.41% | 34,722 | 0% | 0% | $26,962 |
| TWO SIGMA SECURITIES, LLC | 0.29% | 24,764 | 0% | $19,229 | |
| United Community Bank | 0.24% | 20,000 | 0% | 0.01% | $15,530 |
| Revisor Wealth Management LLC | 0.23% | 19,580 | 0% | $15,204 | |
| Arch Global Advisors, LLC | 0.21% | 17,434 | 0% | 0.01% | $13,538 |
| Princeton Global Asset Management LLC | 0.2% | 16,833 | 0% | 0% | $13,071 |
| LPL Financial LLC | 0.18% | 15,034 | +37% | 0% | $11,674 |
| MORGAN STANLEY | 0.14% | 12,096 | -53% | 0% | $9,393 |
| Mariner, LLC | 0.12% | 10,420 | -0.12% | 0% | $8,091 |
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 11,774,850 | $9,144,296 | -$618,566 | $0.78 | 31 |
| 2025 Q4 | 12,450,799 | $9,437,810 | -$1,624,435 | $0.76 | 37 |
| 2025 Q3 | 14,406,380 | $12,801,427 | +$798,232 | $0.89 | 34 |
| 2025 Q2 | 13,532,500 | $9,178,137 | +$7,852,763 | $0.68 | 30 |
| 2025 Q1 | 1,929,327 | $1,640,294 | +$267,014 | $0.85 | 18 |
| 2024 Q4 | 1,618,518 | $1,336,454 | -$822,631 | $0.83 | 20 |
| 2024 Q3 | 2,423,467 | $2,399,034 | -$268,422 | $0.99 | 21 |
| 2024 Q2 | 2,735,360 | $2,187,702 | -$97,024 | $0.80 | 18 |
| 2024 Q1 | 2,846,820 | $3,416,201 | -$33,927 | $1.20 | 18 |
| 2023 Q4 | 2,862,898 | $4,523,339 | +$578,694 | $1.58 | 20 |
| 2023 Q3 | 2,618,184 | $2,331,807 | +$1,492,764 | $0.89 | 18 |
| 2023 Q2 | 938,623 | $1,126,777 | -$44,391 | $1.20 | 13 |
| 2023 Q1 | 962,913 | $1,549,540 | +$453,337 | $1.61 | 14 |
| 2022 Q4 | 722,249 | $866,359 | +$155,582 | $1.20 | 18 |
| 2022 Q3 | 409,378 | $686,000 | +$3,717 | $1.69 | 9 |
| 2022 Q2 | 479,839 | $394,000 | -$269,817 | $0.82 | 8 |
| 2022 Q1 | 707,048 | $777,000 | -$2,285,922 | $1.10 | 8 |
| 2021 Q4 | 1,946,125 | $3,774,000 | +$3,070,716 | $1.94 | 12 |
| 2021 Q3 | 250,733 | $989,000 | -$398,000 | $3.94 | 6 |
| 2021 Q2 | 411,124 | $1,522,205 | +$1,521,000 | $6.63 | 3 |